文档介绍:· 131·
2022年第 24卷第 2期(总第 220期)
un33600,China;3DepartmentofPharmacya,DepartmentofSurgeryb,
ChangzhengHospital,NavalMedicalUniversity(SecondMilitaryMedicalUniversity),Shanghai200003,China)
[Abstract] Objective:Toidentifypotentialdiagnosticbiomarkersandcapecitabinerelatedadverseeffect(CRAE)biomarkersfromuri
naryendogenousmetabolitesinChinesecolorectalcancer(CRC)patientsMethods:Themetabolicprofilesof148CRCpatientsand50
nonneoplasticcontrolswereanalyzedusingultrahighperformanceliquidchromatographycombinedwithquadrupoletimeofflightmass
spectrometry(UHPLCQTOFMS)ThedatawerebioinformaticallyanalyzedandestablishedaCRCpredictivemodelResults:Aseries
ofdiagnosticmarkersforCRCwerefound,including3Hexenedioicacid,Salicylicacid,(R)Athanagrandione,PC(15∶0/20∶4)and
(9E,11E)Octadecadienoic,whicharenonpolarmetabolitesrelatedtolipidmetabolismusingTheROCcurveshowstheareaunderthe
curve(AUC)ofthetrainingsetis0980,(95%CI:0949-0999;Sensitivity:984%;Specificity:926%),theAUCofthetestsetis
1,(Sensitivity:986%;Specificity:100%)Inaddition,(R)athanagrandioneandSalicylicacidcanbecombinedtopredictdiarrhea,
[基金项目] 国家国际科技合作专项项目(项目编号:2015DFA31810;项目名称:肿瘤个体化治疗新型生物标志物的发现与应用);上海市科学技术委员会科研计划
项目(项目编号:19QB1404500;项目名称:结直肠肿瘤靶向代谢组标志物的系统研究);上海申康医院发展中心临床科技创新项目(项目编号:SHDC12015120;项目
名